PILLDirexion Daily Pharmaceutical & Medical Bull 3X Shares ETF
Seeks daily investment results of 300% of the daily performance of the Index.
By Direxion Funds · Launched 2017
Annual Cost
0.98%
#5,220 of 6,040 · expensive
Fund Size
$23M
#4,470 of 6,040 · small
Return (1Y)
+153.7%
Track Record
8 years
#1,654 of 6,040 · established
Performance
Total-return NAV · USDGrowth of $10,000
$23,401+134.0%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaStrategy
Leveraged
Sector
Health careIndex tracked
S&P Pharmaceuticals & Medical Equipment & Devices Select Industry Index
Holdings
By weightConcentration
synthetic exposure — holdings shown are derivatives collateral, not the fund's positions
GOLDMAN FINANCIAL
19.0%
N/A
5.1%
DREYFUS GOVERNMENT CASH MANAGE
3.7%
ORGANON & COMPANY
2.8%
CORCEPT THERAPEUTICS INC
1.8%
ENLIVEN THERAPEUTICS INC
1.8%
AXSOME THERAPEUTICS INC
1.7%
OMEROS CORP
1.6%
PERRIGO COMPANY PLC
1.6%
DEFINIUM THERAPEUTICS INCDFTX
1.6%
Asset allocation
Other
76.2%
Stocks
23.3%
Cash
0.5%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
66.3%High
Year-on-year price swings
Max drawdown
-88.8%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.63Decent risk-adjusted returns
Sortino (3Y)
0.91Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks daily investment results of 300% of the daily performance of the Index.
- Strategy
- Invests primarily in pharmaceutical and medical stocks to achieve 3X daily leveraged exposure to the Index. The Fund is designed to measure performance of stocks in the pharmaceuticals industry, classified under GICS, and rebalances its portfolio daily to maintain this exposure.
- Inception date
- November 15, 2017
- Fund family
- Direxion Funds
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save PILL to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18